Rhumbline Advisers Medtronic PLC Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

A detailed history of Rhumbline Advisers transactions in Medtronic PLC stock. As of the latest transaction made, Rhumbline Advisers holds 2,638,209 shares of MDT stock, worth $204 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,638,209

Previous 2,659,096 0.79%

Holding current value

$204 Million

Previous $219 Million 4.96%

% of portfolio

0.22%

Previous 0.23%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$82.84 - $88.09 $1.73 Million - $1.84 Million	-20,887 Reduced 0.79%	2,638,209 $230 Million
Q4 2023 Feb 08, 2024	SELL	$69.43 - $83.43 $1.56 Million - $1.87 Million	-22,411 Reduced 0.84%	2,659,096 $219 Million
Q3 2023 Nov 09, 2023	BUY	$78.22 - $90.4 $1.09 Million - $1.26 Million	13,950 Added 0.52%	2,681,507 $210 Million
Q2 2023 Aug 08, 2023	BUY	$79.47 - $91.38 $2.37 Million - $2.73 Million	29,845 Added 1.13%	2,667,557 $235 Million
Q1 2023 May 11, 2023	BUY	$76.72 - $87.58 $6.88 Million - $7.85 Million	89,648 Added 3.52%	2,637,712 $213 Million

Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $10 Million - $11.5 Million	131,539 Added 5.44%	2,548,064 $198 Million
Q3 2022 Nov 10, 2022	BUY	$80.75 - $95.31 $4.62 Million - $5.45 Million	57,210 Added 2.42%	2,416,525 $195 Million
Q2 2022 Aug 11, 2022	BUY	$87.4 - $113.09 $8.25 Million - $10.7 Million	94,365 Added 4.17%	2,359,315 $212 Million
Q1 2022 May 12, 2022	BUY	$100.58 - $112.38 $9.4 Million - $10.5 Million	93,462 Added 4.3%	2,264,950 $251 Million
Q4 2021 Feb 10, 2022	BUY	$99.53 - $127.75 $5.44 Million - $6.99 Million	54,698 Added 2.58%	2,171,488 $225 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $6.15 Million - $6.78 Million	-50,125 Reduced 2.31%	2,116,790 $265 Million
Q2 2021 Aug 05, 2021	SELL	$118.19 - $131.5 $12.1 Million - $13.5 Million	-102,718 Reduced 4.53%	2,166,915 $269 Million
Q1 2021 May 06, 2021	SELL	$111.18 - $119.74 $15.6 Million - $16.7 Million	-139,885 Reduced 5.81%	2,269,633 $268 Million
Q4 2020 Feb 10, 2021	BUY	$100.57 - $117.14 $834,831 - $972,379	8,301 Added 0.35%	2,409,518 $282 Million
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $6.49 Million - $7.83 Million	-72,015 Reduced 2.91%	2,401,217 $250 Million
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $7.44 Million - $9.14 Million	88,436 Added 3.71%	2,473,232 $227 Million
Q1 2020 May 06, 2020	BUY	$72.92 - $121.3 $3.27 Million - $5.43 Million	44,797 Added 1.91%	2,384,796 $215 Million
Q4 2019 Feb 05, 2020	BUY	$104.49 - $114.54 $2.46 Million - $2.7 Million	23,553 Added 1.02%	2,339,999 $265 Million
Q3 2019 Oct 23, 2019	BUY	$98.02 - $111.18 $5.95 Million - $6.74 Million	60,662 Added 2.69%	2,316,446 $252 Million
Q2 2019 Aug 14, 2019	SELL	$84.15 - $99.38 $3.92 Million - $4.63 Million	-46,569 Reduced 2.02%	2,255,784 $220 Million
Q1 2019 May 01, 2019	SELL	$82.45 - $93.79 $6.99 Million - $7.96 Million	-84,838 Reduced 3.55%	2,302,353 $210 Million
Q4 2018 Jan 31, 2019	BUY	$85.8 - $99.49 $4.29 Million - $4.98 Million	50,038 Added 2.14%	2,387,191 $217 Million
Q3 2018 Nov 07, 2018	SELL	$85.91 - $99.17 $5.17 Million - $5.96 Million	-60,133 Reduced 2.51%	2,337,153 $230 Million
Q2 2018 Aug 06, 2018	SELL	$77.48 - $87.83 $3.86 Million - $4.37 Million	-49,758 Reduced 2.03%	2,397,286 $205 Million
Q1 2018 May 02, 2018	BUY	$76.55 - $87.26 $289,435 - $329,930	3,781 Added 0.15%	2,447,044 $196 Million
Q4 2017 Feb 09, 2018	BUY	$76.93 - $83.5 $2.09 Million - $2.27 Million	27,156 Added 1.12%	2,443,263 $197 Million
Q3 2017 Nov 06, 2017	BUY	$77.71 - $84.6 $188 Million - $204 Million	2,416,107	2,416,107 $188 Million

Others Institutions Holding MDT

# of Institutions

2,239

Shares Held

1.05B

Call Options Held

6.1M

Put Options Held

7.84M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $103B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Medtronic PLC Transaction History